Innoviva, Inc. (INVA) Financials
INVA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 1.8 billion | 494.9 million |
| Dec. 31, 2025 | 1.6 billion | 462.3 million |
| Sept. 30, 2025 | 1.4 billion | 419.2 million |
| June 30, 2025 | 1.3 billion | 618.8 million |
INVA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 34.8 million | ? |
| Dec. 31, 2025 | 53.4 million | 16.2 million |
| Sept. 30, 2025 | 48.6 million | 2.4 million |
| June 30, 2025 | 44.1 million | 2.4 million |
INVA Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2026 | 186.6 million |
| Dec. 31, 2025 | 241.7 million |
| Sept. 30, 2025 | 89.9 million |
| June 30, 2025 | 63.7 million |
INVA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 611.9 million | 315.4 million | 10.7 million |
| Dec. 31, 2025 | 550.9 million | 257.7 million | 10.9 million |
| Sept. 30, 2025 | 533.1 million | 313.9 million | 1.6 million |
| June 30, 2025 | 497.7 million | 257.0 million | 2.0 million |
INVA Shares Outstanding
INVA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 492000 | 5.2 million | 32.4 million | - |
| Dec. 31, 2025 | 1.1 million | 4.6 million | 32.1 million | - |
| Sept. 30, 2025 | 1.1 million | 13.7 million | 27.4 million | - |
| June 30, 2025 | - | 8.0 million | 26.4 million | - |
INVA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 98.0 million | 22.2 million |
| Dec. 31, 2025 | 118.0 million | 42.4 million |
| Sept. 30, 2025 | 107.8 million | 25.8 million |
| June 30, 2025 | 100.3 million | 10.6 million |
INVA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
INVA
Price: $22.42
52 week price:
Payout Ratio Range:
Earnings Per Share: 6.26 USD
P/E Ratio: 3.60
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 549332
Ebitda: 66.9 millionMarket Capitalization: 1.6 billion